These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10425382)

  • 41. Carbonic anhydrase inhibitors: design of thioureido sulfonamides with potent isozyme II and XII inhibitory properties and intraocular pressure lowering activity in a rabbit model of glaucoma.
    Mincione F; Starnotti M; Masini E; Bacciottini L; Scrivanti C; Casini A; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3821-7. PubMed ID: 16039853
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 3-substituted thieno[2,3-b][1,4]thiazine-6-sulfonamides. A novel class of topically active carbonic anhydrase inhibitors.
    Hunt CA; Mallorga PJ; Michelson SR; Schwam H; Sondey JM; Smith RL; Sugrue MF; Shepard KL
    J Med Chem; 1994 Jan; 37(2):240-7. PubMed ID: 8295211
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and physicochemical properties of thiadiazolo[3,2-a]pyrimidinesulfonamides and thiadiazolo[3,2-a]triazinesulfonamides as candidates for topically effective carbonic anhydrase inhibitors.
    Katritzky AR; Caster KC; Maren TH; Conroy CW; Bar-Ilan A
    J Med Chem; 1987 Nov; 30(11):2058-62. PubMed ID: 3669014
    [TBL] [Abstract][Full Text] [Related]  

  • 44. QSAR study on carbonic anhydrase inhibitors: water-soluble sulfonamides incorporating beta-alanyl moieties, possessing long lasting-intra ocular pressure lowering properties--a molecular connectivity approach.
    Agrawal VK; Banerji M; Gupta M; Singh J; Khadikar PV; Supuran CT
    Eur J Med Chem; 2005 Oct; 40(10):1002-12. PubMed ID: 15961191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design, synthesis, and evaluation of NO-donor containing carbonic anhydrase inhibitors to lower intraocular pressure.
    Huang Q; Rui EY; Cobbs M; Dinh DM; Gukasyan HJ; Lafontaine JA; Mehta S; Patterson BD; Rewolinski DA; Richardson PF; Edwards MP
    J Med Chem; 2015 Mar; 58(6):2821-33. PubMed ID: 25728019
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Carbonic anhydrase inhibitors. Inhibition of the membrane-bound human and bovine isozymes IV with sulfonamides.
    Innocenti A; Firnges MA; Antel J; Wurl M; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1149-54. PubMed ID: 15686931
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The development of topically acting carbonic anhydrase inhibitors as antiglaucoma agents.
    Mincione F; Scozzafava A; Supuran CT
    Curr Pharm Des; 2008; 14(7):649-54. PubMed ID: 18336310
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thienothiopyran-2-sulfonamides: a novel class of water-soluble carbonic anhydrase inhibitors.
    Ponticello GS; Freedman MB; Habecker CN; Lyle PA; Schwam H; Varga SL; Christy ME; Randall WC; Baldwin JJ
    J Med Chem; 1987 Apr; 30(4):591-7. PubMed ID: 3560154
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Topically active carbonic anhydrase inhibitors. 4. [(Hydroxyalkyl)sulfonyl]benzene and [(hydroxyalkyl)sulfonyl]thiophenesulfonamides.
    Shepard KL; Graham SL; Hudcosky RJ; Michelson SR; Scholz TH; Schwam H; Smith AM; Sondey JM; Strohmaier KM; Smith RL
    J Med Chem; 1991 Oct; 34(10):3098-105. PubMed ID: 1920359
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cyclodextrin complexation highly enhances efficacy of arylsulfonylureido benzenesulfonamide carbonic anhydrase inhibitors as a topical antiglaucoma agents.
    Bragagni M; Bozdag M; Carta F; Scozzafava A; Lanzi C; Masini E; Mura P; Supuran CT
    Bioorg Med Chem; 2015 Sep; 23(18):6223-7. PubMed ID: 26319622
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Topically active ocular carbonic anhydrase inhibitors: novel biscarbonylamidothiadiazole sulfonamides as ocular hypotensive agents.
    Pierce WM; Sharir M; Waite KJ; Chen D; Kaysinger KK
    Proc Soc Exp Biol Med; 1993 Jul; 203(3):360-5. PubMed ID: 8516347
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis of a new series of dithiocarbamates with effective human carbonic anhydrase inhibitory activity and antiglaucoma action.
    Bozdag M; Carta F; Vullo D; Akdemir A; Isik S; Lanzi C; Scozzafava A; Masini E; Supuran CT
    Bioorg Med Chem; 2015 May; 23(10):2368-76. PubMed ID: 25846066
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion.
    Brechue WF; Maren TH
    Exp Eye Res; 1993 Jul; 57(1):67-78. PubMed ID: 8405174
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics, acid-base balance and intraocular pressure effects of ethyloxaloylazolamide--a novel topically active carbonic anhydrase inhibitor.
    Sharir M; Pierce WM; Chen D; Zimmerman TJ
    Exp Eye Res; 1994 Jan; 58(1):107-16. PubMed ID: 8157096
    [TBL] [Abstract][Full Text] [Related]  

  • 55. N-Substituted sulfonamide carbonic anhydrase inhibitors with topical effects on intraocular pressure.
    Duffel MW; Ing IS; Segarra TM; Dixson JA; Barfknecht CF; Schoenwald RD
    J Med Chem; 1986 Aug; 29(8):1488-94. PubMed ID: 3735316
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preclinical overview of brinzolamide.
    DeSantis L
    Surv Ophthalmol; 2000 Jan; 44 Suppl 2():S119-29. PubMed ID: 10665514
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
    Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3102-8. PubMed ID: 15905091
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides.
    Vullo D; Franchi M; Gallori E; Pastorek J; Scozzafava A; Pastorekova S; Supuran CT
    Bioorg Med Chem Lett; 2003 Mar; 13(6):1005-9. PubMed ID: 12643899
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison of L-671,152 and MK-927, two topically effective ocular hypotensive carbonic anhydrase inhibitors, in experimental animals.
    Sugrue MF; Mallorga P; Schwam H; Baldwin JJ; Ponticello GS
    Curr Eye Res; 1990 Jun; 9(6):607-15. PubMed ID: 2117519
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
    Sławiński J; Szafrański K; Vullo D; Supuran CT
    Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.